Generic Status Epilepticus Treatment Now Available

Mylan launches generic Cerebyx Injection
Mylan launches generic Cerebyx Injection

Mylan announced the availability of Fosphenytoin Sodium Injection, the generic version of Pfizer's Cerebyx Injection. 

Fosphenytoin Sodium, a hydantoin, is indicated for the control of generalized tonic-clonic status epilepticus and for the prevention and treatment of seizures occurring during neurosurgery. Fosphenytoin Sodium can also be substituted, short-term, for oral phenytoin. It should be used only when oral phenytoin administration is not feasible; it must not be given orally. 

Related Articles

Fosphenytoin is a prodrug of phenytoin and its anticonvulsant effects are attributable to phenytoin. It is thought to work by modulating voltage-dependent sodium channels of neurons, inhibiting calcium flux across neuronal membranes, modulating voltage-dependent calcium channels of neurons, and enhancing sodium-potassium ATPase activity of neurons and glial cells. 

Fosphenytoin Sodium Injection is available as 75mg/mL (50mg phenytoin sodium equivalents [PE]/mL), packaged in 100mg PE/2mL and 500mg PE/10mL single-use vials. 

For more information call (800) RX-MYLAN or visit Mylan.com.